Table 4.

Cholesterol, HDL, LDL, TG in three points (before treatment, at the end of treatment and 6 months after treatment) in both groups of participants

	Group II
	N	Mean ± SD	N	Mean ± SD	P value
Cholesterol (mmol/l)
BT	35	4.16 ± 1.3	35	4.38 ± 0.9	A0.41
ET	35	3.83 ± 1.3	35	4.43 ± 0.7	B0.0008**
AT	35	4.47 ± 1.4	35	4.89 ± 1.1	B0.038*
HDL (mmol/l)
BT	35	1.12 ± 0.3	35	1.17 ± 0.3	A0.5
ET	35	0.97± 0.3	35	1.1 ± 0.3	B0.02*
AT	35	2.0 ± 0.35	35	1.2 ± 0.2	B0.36
LDL (mmol/l)
BT	35	2.47 ± 1.1	35	2.61 ± 0.8	A0.53
ET	35	2.16 ± 1.1	35	2.56 ± 0.6	A0.06
AT	35	2.77 ± 1.2	35	3.04 ± 1.1	A0.33
TG (mmol/l)
BT	35	1.17 ± 0.6	35	1.14 ± 0.6	B0.9
ET	35	1.39 ± 0.6	35	1.71 ± 2.3	B0.8
AT	35	1.32 ± 0.6	35	1.32 ± 0.7	B0.9

Group I (with Atorvastatin), group II (without Atorvastatin); ^a(Student t test); ^b(Mann-Whitney test);

^*p < 0.05;

^**p < 0.01; BT - before treatment; ET-end of treatment; AT-after treatment (6 months).